Gabapentin News and Research

RSS
Gabapentin (brand name Neurontin) is a medication originally developed for the treatment of epilepsy. Presently, gabapentin is widely used to relieve pain, especially neuropathic pain.
Antidepressants and anti-seizure drugs can effectively treat diabetic nerve pain, research finds

Antidepressants and anti-seizure drugs can effectively treat diabetic nerve pain, research finds

New position statement offers recommendations for physicians on prevention of diabetic neuropathy

New position statement offers recommendations for physicians on prevention of diabetic neuropathy

Electro-acupuncture may be effective in treating sleep disturbances in women with breast cancer

Electro-acupuncture may be effective in treating sleep disturbances in women with breast cancer

Study finds high rate of misuse of seizure and pain drug

Study finds high rate of misuse of seizure and pain drug

Anticonvulsant medication gabapentin effectively reduces common complication of PONV

Anticonvulsant medication gabapentin effectively reduces common complication of PONV

Breckenridge Pharmaceutical announces final FDA approval for Gabapentin Oral Solution

Breckenridge Pharmaceutical announces final FDA approval for Gabapentin Oral Solution

American Pain Society releases new post-surgical pain management guideline

American Pain Society releases new post-surgical pain management guideline

Noninvasive FMRI may help evaluate effectiveness of new pain medications

Noninvasive FMRI may help evaluate effectiveness of new pain medications

Endocrine Society issues Clinical Practice Guideline on treatment of menopausal symptoms

Endocrine Society issues Clinical Practice Guideline on treatment of menopausal symptoms

NAMS panel provides recommendations to help women manage menopause-associated vasomotor symptoms

NAMS panel provides recommendations to help women manage menopause-associated vasomotor symptoms

Acupuncture may be viable treatment for women experiencing hot flashes

Acupuncture may be viable treatment for women experiencing hot flashes

Acupuncture: A viable treatment for breast cancer survivors experiencing hot flashes

Acupuncture: A viable treatment for breast cancer survivors experiencing hot flashes

Unituxin (dinutuximab) granted EC Marketing Authorisation for treatment of childhood neuroblastoma

Unituxin (dinutuximab) granted EC Marketing Authorisation for treatment of childhood neuroblastoma

Depomed acquires U.S. rights to NUCYNTA franchise from Janssen Pharmaceuticals

Depomed acquires U.S. rights to NUCYNTA franchise from Janssen Pharmaceuticals

Researchers investigate effects of neuromodulatory medication on orofacial tissue

Researchers investigate effects of neuromodulatory medication on orofacial tissue

Unmet medication need in neuropathic pain

Unmet medication need in neuropathic pain

Perampanel does not offer added benefit for patients with Epilepsy

Perampanel does not offer added benefit for patients with Epilepsy

XenoPort initiates XP23829 Phase 2 clinical trial in patients with psoriasis

XenoPort initiates XP23829 Phase 2 clinical trial in patients with psoriasis

Study determines effectiveness of gabapentin for treatment of vulvodynia in women

Study determines effectiveness of gabapentin for treatment of vulvodynia in women

XenoPort reports net loss of $19.1 million for fourth quarter 2013

XenoPort reports net loss of $19.1 million for fourth quarter 2013